PC
Paul Choi Goldman Sachs Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
AMRN
1
Amarin Corp
AMRN
$317M
| $15.33 | $12 |
22%
downside
| Sell |
25 Jun ‘25
2 months ago |
|
2
UroGen Pharma
URGN
$873M
| $18.88 | $3 |
84%
downside
| Neutral |
22 May ‘25
3 months ago |
|
3
Gossamer Bio
GOSS
$668M
| $2.94 | $8 |
172%
upside
| Buy |
16 May ‘25
3 months ago |
|
4
Phathom Pharmaceuticals
PHAT
$875M
| $12.34 | $5 |
59%
downside
| Neutral |
2 May ‘25
4 months ago |
|
5
Arvinas
ARVN
$575M
| $7.83 | $8 |
2%
upside
| Neutral |
2 May ‘25
4 months ago |
|
6
Xenon Pharmaceuticals
XENE
$3.02B
| $39.21 | $52 |
33%
upside
| Buy |
17 Apr ‘25
4 months ago |
|
7
Vir Biotechnology
VIR
$732M
| $5.27 | $21 |
298%
upside
| Buy |
17 Apr ‘25
4 months ago |
|
8
Regenxbio
RGNX
$490M
| $9.71 | $12 |
24%
upside
| Neutral |
17 Apr ‘25
4 months ago |
|
9
Esperion Therapeutics
ESPR
$540M
| $2.68 | $3 |
12%
upside
| Neutral |
17 Apr ‘25
4 months ago |
|
10
Dynavax Technologies
DVAX
$1.18B
| $10.06 | $10 |
1%
downside
| Sell |
17 Apr ‘25
4 months ago |
|
11
Ascendis Pharma
ASND
$12.5B
| $205.91 | $225 |
9%
upside
| Buy |
13 Feb ‘25
6 months ago |
|
12
Lantheus
LNTH
$3.72B
| $54.75 | $143 |
161%
upside
| Buy |
18 Dec ‘24
8 months ago |
|
13
PTC Therapeutics
PTCT
$4.55B
| $57.26 | $42 |
27%
downside
| Sell |
4 Dec ‘24
9 months ago |
|
14
Cytokinetics
CYTK
$6.34B
| $53.01 | $60 |
13%
upside
| Neutral |
13 Aug ‘24
1 year ago |
|
15
HUTCHMED
HCM
$2.74B
| $15.97 | $19 |
19%
upside
| Neutral |
1 Aug ‘24
1 year ago |
|
16
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $35.71 | $32 |
10%
downside
| Buy |
26 Jul ‘23
2 years ago |
|
17
BridgeBio Pharma
BBIO
$10.2B
| $53.38 | $50 |
6%
downside
| Buy |
18 Jul ‘23
2 years ago |
|
18
Foghorn Therapeutics
FHTX
$326M
| $5.77 | $19 |
229%
upside
| Buy |
29 Jun ‘23
2 years ago |
|
19
FibroGen
FGEN
$48.9M
| $12.10 | $50 |
313%
upside
| Sell |
27 Jun ‘23
2 years ago |
|
20
PMV Pharmaceuticals
PMVP
$77.4M
| $1.46 | $25 |
1,612%
upside
| Buy |
24 May ‘22
3 years ago |
|
21
Korro Bio
KRRO
$312M
| $33.18 | $100 |
201%
upside
| Neutral |
24 May ‘22
3 years ago |
|
22
ARS Pharmaceuticals
SPRY
$995M
| $10.07 | $3.50 |
65%
downside
| Neutral |
4 Apr ‘22
3 years ago |
|
23
Puma Biotechnology
PBYI
$253M
| $5.03 | $8 |
59%
upside
| Sell |
6 Aug ‘21
4 years ago |
|
24
Neurocrine Biosciences
NBIX
$14.3B
| $144.10 | $135 |
6%
downside
| Neutral |
29 Jun ‘20
5 years ago |
|
25
Dianthus Therapeutics
DNTH
$853M
| $26.50 | $240 |
806%
upside
| Buy |
8 Jun ‘20
5 years ago |
|